These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 19558259)

  • 1. Worsening psychosis induced by varenicline in a hospitalized psychiatric patient.
    DiPaula BA; Thomas MD
    Pharmacotherapy; 2009 Jul; 29(7):852-7. PubMed ID: 19558259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varenicline-associated acute renal failure.
    Bird ML; Vesta KS
    Ann Pharmacother; 2008 Dec; 42(12):1908-11. PubMed ID: 18984856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hepatic injury associated with varenicline in a patient with underlying liver disease.
    Franck AJ; Sliter LR
    Ann Pharmacother; 2009 Sep; 43(9):1539-43. PubMed ID: 19638471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
    Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
    Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varenicline-induced mania in a bipolar patient.
    Alhatem F; Black JE
    Clin Neuropharmacol; 2009; 32(2):117-8. PubMed ID: 19512966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A manic episode in a 64-year-old man: an adverse effect of varenicline.
    Ahmed AI
    Gen Hosp Psychiatry; 2011; 33(2):200.e9-200.e11. PubMed ID: 21596218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
    J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of varenicline for smoking cessation.
    Hays JT; Ebbert JO; Sood A
    Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies.
    Cerimele JM; Durango A
    J Clin Psychiatry; 2012 Aug; 73(8):e1039-47. PubMed ID: 22967780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline precipitating psychosis in a patient with no previous psychiatric history: a case report of a Spanish patient who was later diagnosed with paranoid personality disorder.
    Forcen FE; Martinez FL; Moya AM
    Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):221-3. PubMed ID: 22182460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New drugs; varenicline].
    van Bronswijk H; Dubois EA; Zitman FG; Cohen AF
    Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2503-4. PubMed ID: 18062594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varenicline in smoking cessation.
    Tonstad S; Rollema H
    Expert Rev Respir Med; 2010 Jun; 4(3):291-9. PubMed ID: 20524911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
    Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical implementation of varenicline as an aid to smoking cessation in clinical practice.
    Tonstad S
    Pneumologia; 2009; 58(3):167-74. PubMed ID: 19817313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S; Patel PN
    Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of nicotine dependence with Chantix (varenicline).
    Rankin KV; Jones DL
    Tex Dent J; 2011 May; 128(5):457-61. PubMed ID: 21834368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline induces manic relapse in bipolar disorder.
    Knibbs N; Tsoi DT
    Gen Hosp Psychiatry; 2011; 33(6):641.e1-2. PubMed ID: 21749843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
    Garza D; Murphy M; Tseng LJ; Riordan HJ; Chatterjee A
    Biol Psychiatry; 2011 Jun; 69(11):1075-82. PubMed ID: 21295286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination treatment with varenicline and nicotine replacement therapy.
    Ebbert JO; Burke MV; Hays JT; Hurt RD
    Nicotine Tob Res; 2009 May; 11(5):572-6. PubMed ID: 19351781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse neuropsychiatric events associated with varenicline use in veterans: a case series.
    Cantrell M; Argo T; Haak L; Janney L
    Issues Ment Health Nurs; 2012 Oct; 33(10):665-9. PubMed ID: 23017042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.